Pan India Corpor (511525)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Stated book value of ₹0.65 per share provides a tangible net asset benchmark for an investment company.
• Absolute losses are tiny in the latest quarter, roughly -₹0 Cr, so there is no severe cash drain visible.
• Listed status on NSE/BSE makes the small ₹50 Cr market cap accessible to retail investors.
• As an investment company, changes in its underlying portfolio can be tracked and monitored.
• Low absolute share price of ₹2.21 gives it speculative appeal, though not investment merit.

Concerns

• Piotroski F-Score of 2/9 signals very poor financial health and a high risk of further deterioration.
• Negative ROE of -4.07% and deeply negative ROCE of -36.35% show the underlying assets are losing money.
• P/B of 3.40 means the market price of ₹2.21 is far above book value of ₹0.65, leaving no margin of safety.
• Profit growth is -66.67%, with no sales, no dividend, and no promoter holding disclosure, making the stock purely speculative.

AI Analysis

Let me look at Pan India Corpor with the same eyes I would use for any business. First, what does it earn? It earns nothing. Sales are zero, and the latest quarter shows a net loss of roughly ₹0 Cr. Over a year, profit growth has fallen 66.67%, ROE is -4.07% and ROCE is -36.35%. This is not a business; it is an investment entity holding assets, and those assets are not generating acceptable returns. Benjamin Graham taught me to use book value as a starting point. Here book value is ₹0.65 per share, so the ₹2.21 price means I am paying 3.4 times net assets. For that premium, I require strong profitability, a clear moat, or a catalyst. None exists. The Piotroski F-Score of 2 out of 9 is a distress signal. No dividend is coming to me as I wait. The 52-week range of ₹1.35 to ₹2.70 tells me the market is speculating, not valuing. With a market cap of ₹50 crore and no earnings, the P/E is meaningless. If I own the shares, I am relying entirely on someone else paying more. That is not investment; it is speculation. In the classic Graham framework, an asset play needs a discount to net asset value. Here I am asked to pay a 240% premium to book value for a company whose returns on capital are deeply negative. I would rather keep my cash. The only thing that would interest me is evidence of hidden assets or a credible turnaround in the underlying portfolio. Until I see that, Pan India Corpor remains a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer